GIUSTI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 5.956
EU - Europa 4.615
AS - Asia 2.515
SA - Sud America 328
Continente sconosciuto - Info sul continente non disponibili 74
AF - Africa 69
OC - Oceania 41
Totale 13.598
Nazione #
US - Stati Uniti d'America 5.877
PL - Polonia 1.596
RU - Federazione Russa 1.198
IT - Italia 773
SG - Singapore 724
CN - Cina 578
HK - Hong Kong 420
VN - Vietnam 311
BR - Brasile 266
SE - Svezia 245
IE - Irlanda 236
KR - Corea 184
FI - Finlandia 127
FR - Francia 126
DE - Germania 119
IN - India 76
GB - Regno Unito 74
CA - Canada 40
AU - Australia 38
JP - Giappone 37
JO - Giordania 34
ID - Indonesia 33
AR - Argentina 29
BE - Belgio 24
BD - Bangladesh 23
TR - Turchia 19
CI - Costa d'Avorio 18
NL - Olanda 18
IQ - Iraq 17
UA - Ucraina 17
ES - Italia 14
CH - Svizzera 12
MX - Messico 12
PK - Pakistan 12
ZA - Sudafrica 12
CO - Colombia 8
DO - Repubblica Dominicana 8
UZ - Uzbekistan 8
DZ - Algeria 7
EC - Ecuador 7
NG - Nigeria 7
RO - Romania 7
MA - Marocco 6
SA - Arabia Saudita 6
CL - Cile 5
CZ - Repubblica Ceca 5
IL - Israele 5
JM - Giamaica 5
KE - Kenya 5
LT - Lituania 4
LV - Lettonia 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CR - Costa Rica 3
HU - Ungheria 3
KZ - Kazakistan 3
MY - Malesia 3
SV - El Salvador 3
VE - Venezuela 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
CG - Congo 2
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
KW - Kuwait 2
LK - Sri Lanka 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
SC - Seychelles 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AI - Anguilla 1
AO - Angola 1
AT - Austria 1
BJ - Benin 1
ET - Etiopia 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
SI - Slovenia 1
Totale 13.522
Città #
Warsaw 1.593
Santa Clara 1.221
Ashburn 736
Fairfield 536
Singapore 479
Hong Kong 363
Chandler 287
Woodbridge 243
Dublin 236
Seattle 226
Cambridge 217
Houston 204
San Jose 203
Seoul 179
Beijing 172
Ann Arbor 169
Wilmington 168
Milan 104
Ho Chi Minh City 103
Lawrence 84
Altamura 79
Florence 70
Princeton 70
Los Angeles 68
Hefei 67
Buffalo 66
Lauterbourg 63
Munich 63
Hanoi 60
The Dalles 58
Rome 55
Helsinki 54
Boston 52
Council Bluffs 51
Shanghai 43
New York 41
Dallas 38
Melbourne 36
Mumbai 34
Boardman 32
Medford 31
San Diego 31
São Paulo 31
Phoenix 29
Tokyo 29
Naples 28
Jakarta 27
Paris 27
Turin 25
Dong Ket 24
Moscow 23
Brussels 22
Clifton 22
Turku 22
Abidjan 18
Kent 18
Pune 16
Redondo Beach 16
Palermo 15
Andover 13
Da Nang 13
Haiphong 13
Jacksonville 13
Norwalk 13
Orem 13
Bern 12
Falls Church 12
Rio de Janeiro 12
Bologna 11
Frankfurt am Main 11
Lappeenranta 10
London 10
Yubileyny 10
Bari 9
Brooklyn 8
Izmir 8
Montreal 8
Renton 8
Brescia 7
Chicago 7
Denver 7
Figino 7
Johannesburg 7
Lyon 7
Miami 7
Philadelphia 7
Stockholm 7
Toronto 7
Washington 7
Abuja 6
Atlanta 6
Baghdad 6
Bengaluru 6
Durham 6
Hillsboro 6
Manchester 6
North Bergen 6
Salerno 6
Tashkent 6
Venice 6
Totale 9.427
Nome #
Natural History of MEN1 GEP-NET: Single-Center Experience After a Long Follow-Up. 343
Management impact: effects on quality of life and prognosis in MEN1 341
Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database 335
Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens 330
MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors 328
The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the "Knudson's second hit". 320
Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign. 312
Correction to: Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database. 309
Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology 301
Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update 279
Calcium Intake in Bone Health: A Focus on Calcium-Rich Mineral Waters 274
Thyroid cancer: current molecular perspectives. 273
A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. 270
The LARO-MEN1 study: a longitudinal clinical experience with octreotide Long-Acting Release in patients with Multiple Endocrine Neoplasia type 1 Syndrome 264
Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity. 245
When Parathyroidectomy Should Be Indicated or Postponed in Adolescents With MEN1-Related Primary Hyperparathyroidism 241
Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients 219
Blomstrand’s chondrodysplasia 214
Total and Subtotal Parathyroidectomy in Young Patients With Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism: Potential Post-surgical Benefits and Complications 213
Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database 211
A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome. 210
Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report. 208
Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. 197
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease. 194
DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes 192
Circulating MicroRNAs as Biomarkers of Osteoporosis and Fragility Fractures 188
Calcifediol: mechanisms of action 185
Hereditary hyperparathyroidism syndromes. 183
Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization. 183
CYP19 and ESR1 gene polymorphisms: response of the bone mineral density in post-menopausal women to hormonal replacement therapy 182
Calcolosi renale recidivante: una nnuova mutazione del gene codificante il recettore del calcio( CASR) 182
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1) 178
Genetic predictors of skeletal outcomes in healthy fertile women: The Bonturno Study. 177
Construction of a database for the evaluation and the clinical management of patients with breast cancer treated with antiestrogens and/or aromatase inhibitors. 177
Genetic test in multiple endocrine neoplasia type 1 syndrome: An evolving story. 172
Oxidative Stress and Inflammation in Osteoporosis: Molecular Mechanisms Involved and the Relationship with microRNAs 172
Sarcomatoid carcinoma of the kidney in a MEN1 patient: Case report and genetic profile. 171
Osteonecrosis of the jaw in a patient with rheumatoid artritis treated with an oral aminobisphosphonate: a clinical case report. 169
Osteonecrosis of the Jaw In A Patient With Rheumatoid Artritis Treated With An Oral Aminobisphosphonate: A Clinical Case Report 168
Variazioni molecolari del gene codificante la fosfatasi alcalina: correlazione con la massa ossea (BMD) e i markers biochimici di turnover osseo 160
Endocrine sequelae of hematopoietic stem cell transplantation: Effects on mineral homeostasis and bone metabolism 159
Soft tissue postraumatic calcifications associated with a new FGF23 gene mutation: clinicopathological and molecular genetic study 158
Haplotype analysis of two pairs of unrelated Italian families affected by Paget's disease of bone, exhibiting different geographical origins and two different mutations of p62/sequestosomel gene, supports the evidence for common founders. 158
Carcinoma mammario e osteoporosi: risultati preliminari di uno studio fiorentino 157
Calcifediol: Why, When, How Much? 156
Un particolare caso di iperparatiroidismo primitivo giovanile 156
Molecular diagnosis of parathyroid carcinoma: a reality in the near future. 155
[Left laparoscopic adrenalectomy for pheochromocytoma in MEN 2B: case report]. 152
Prevalence of Osteoporosis and Risk Factors For Bone Demineralization In Italy: First Results From the Firmo Study 151
Un nuovo caso di sclerosi ossea: osteopochilosi 150
Fracture unit: a (possible) model of implementation in Italy. 147
A New Fgf23 Gene Polymorphism: Possible Role In the Pathogenesis of the Development of Extraskeletal Calcifications? 146
Association of vitamin D and bisphenol A levels with cardiovascular risk in an elderly Italian population: results from the InCHIANTI study 145
ALPL genotypes in patients with atypical femur fractures or other biochemical and clinical signs of hypophosphatasia 145
Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens: response to comments by Chen et al. 143
Association between vitamin D and bisphenol A levels in an elderly Italian population: results from the InCHIANTI study 143
Genetic Determinants of inherited endocrine tumors: do they have a direct role in bone metabolism regulation and osteoporosis? 142
Efficacy of Cinacalcet Therapy In Patients Affected By Primary Hyperparathyroidism Associated To Multiple Endocrine Neoplasia Syndrome Type 1 (men1): Preliminary Results of the Florentine Study 139
Genotype-Phenotype Correlation Analyses in an Italian MEN1 Series. MEN1 Gene Mutational Performed at the Center for Hereditary Endocrine Tumors of Florence 136
Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 132
THE EFFECTS OF RH-PTH (1-34) ON BONE METABOLISM IN HYPOPARATHYROID PATIENTS 131
Prevalenza dell'osteoporosi e dei principale fattori di rischio nella popolazione italiana: risultiati del BOne tour 2012 129
Tricho-rhino-phalangeal syndrome: role of different methods of measuring bone density 126
High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fracture 125
Pancreatic neuroendocrine tumors in MEN1 patients: difference in post-operative complications and tumor progression between major and minimal pancreatic surgeries 123
A NOVEL TISSUE-NONSPECIFIC ISOENZYME OF ALKALINE PHOSPHATASE (TNSALP) MUTATION IN ADULT PATIENT WITH LOW BONE MASS AND MUSCULOSKELETAL SYMPTOMS 121
CALCIFICATIONS IN DERMATOMYOSITIS: A CLINICAL CASE WITH AN ALTERATION OF PHOSPHATE HOMEOSTASIS, CARRIER OF A NEW FGF23 GENE MUTATION 117
Osteogenesis Imperfecta: Realization of A Multidisciplinar Network To Improve Information, Expertise and Resources 113
Multiple Endocrine Neoplasia Type 1 111
Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery? 108
RETROSPECTIVE COHORT STUDY OF PATIENTS AFFECTED BY CHRONIC HYPOPARATHYROIDISM 81
Serums miR-24-3p and miR-1301-3p as potential biomarkers in MEN1 syndrome 43
Evolving our understanding of vitamin D, periostin levels and cardiovascular risk in the elderly: a cross sectional study 19
Osteopetrosis: Pathogenesis, Clinical Management, and Emerging Therapies 11
Totale 13.598
Categoria #
all - tutte 35.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.666


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022438 0 41 30 21 23 15 21 38 18 28 74 129
2022/20231.178 117 265 39 86 83 200 140 58 134 11 23 22
2023/2024574 12 50 80 22 23 81 35 216 10 14 21 10
2024/20253.490 124 347 239 529 1.107 417 48 217 162 57 132 111
2025/20263.753 459 499 282 306 394 160 483 180 194 271 80 445
2026/2027184 146 38 0 0 0 0 0 0 0 0 0 0
Totale 13.598